{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:33:29Z","timestamp":1777365209062,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Netherlands Ministry of Health Welfare and Sport","doi-asserted-by":"publisher","award":["329517"],"award-info":[{"award-number":["329517"]}],"id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jamda.2024.105474","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:31:12Z","timestamp":1738942272000},"page":"105474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adherence to Guideline Recommendations on Psychotropic Drug Use for Challenging Behavior in Dementia"],"prefix":"10.1016","volume":"26","author":[{"given":"Joury","family":"van der Griend","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenne","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary Y.C.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ineke J.","family":"Gerridzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karlijn J.","family":"Joling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sytse U.","family":"Zuidema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Smalbrugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5994-0652","authenticated-orcid":false,"given":"Eefje M.","family":"Sizoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2024.105474_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MLR.0b013e31818457ce","article-title":"Predictors of nursing home admission for persons with dementia","volume":"47","author":"Gaugler","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2024.105474_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/gps.1858","article-title":"Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study","volume":"23","author":"Steinberg","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105474_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jamda.2012.09.027","article-title":"The prevalence and course of neuropsychiatric symptoms in nursing home patients with dementia: a systematic review","volume":"14","author":"Selbaek","year":"2013","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105474_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/gps.1722","article-title":"Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia","volume":"22","author":"Zuidema","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105474_bib8","author":"Zuidema"},{"key":"10.1016\/j.jamda.2024.105474_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/gps.3858","article-title":"The impact of antipsychotics and neuropsychiatric symptoms on the quality of life of people with dementia living in nursing homes","volume":"28","author":"van de Ven-Vakhteeva","year":"2013","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105474_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13607863.2013.819834","article-title":"Behavioural and psychological symptoms of dementia and their management in care homes within the East of England: a postal survey","volume":"18","author":"Backhouse","year":"2014","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.jamda.2024.105474_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s002280100348","article-title":"Psychotropic drug use in nursing homes--diagnostic indications and variations between institutions","volume":"57","author":"Ruths","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2024.105474_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000448806","article-title":"Characteristics associated with quality of life in long-term care residents with dementia: a cross-sectional study","volume":"42","author":"Klapwijk","year":"2016","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jamda.2024.105474_bib13","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1111\/jocn.12066","article-title":"Distress experienced by nurses in response to the challenging behaviour of residents - evidence from German nursing homes","volume":"21","author":"Schmidt","year":"2012","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1016\/j.jamda.2024.105474_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2850.2006.00964.x","article-title":"Aggressive behaviour by people with dementia in residential care settings: a review","volume":"13","author":"Pulsford","year":"2006","journal-title":"J\u00a0Psychiatr Ment Health Nurs"},{"key":"10.1016\/j.jamda.2024.105474_bib15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijnurstu.2013.02.005","article-title":"Factors associated with quality of life of people with dementia in long-term care facilities: a systematic review","volume":"50","author":"Beerens","year":"2013","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.jamda.2024.105474_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/inr.12293","article-title":"Nursing staff stress from challenging behaviour of residents with dementia: a concept analysis","volume":"63","author":"Hazelhof","year":"2016","journal-title":"Int Nurs Rev"},{"key":"10.1016\/j.jamda.2024.105474_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1017\/S1041610212001627","article-title":"Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review","volume":"25","author":"Seitz","year":"2013","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2024.105474_bib19","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2011.1360","article-title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis","volume":"306","author":"Maher","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2024.105474_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JCP.0b013e3182a6096e","article-title":"Use and safety of antipsychotics in behavioral disorders in elderly people with dementia","volume":"34","author":"Gareri","year":"2014","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2024.105474_bib21","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2024.105474_bib22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1017\/S1041610220004032","article-title":"Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis","volume":"33","author":"Jester","year":"2021","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2024.105474_bib23","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1017\/S1041610216001150","article-title":"Psychotropic drug prescriptions in Western European nursing homes","volume":"28","author":"Janus","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2024.105474_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gps.5697","article-title":"Time trends in psychotropic drug prescriptions in Dutch nursing home residents with dementia between 2003 and 2018","volume":"37","author":"Du","year":"2022","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105474_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029172","article-title":"Potentially inappropriate prescribing in dementia: a state-of-the-art review since 2007","volume":"10","author":"Delgado","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2024.105474_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ageing\/afx147","article-title":"Potentially inappropriate medication among people with dementia in eight European countries","volume":"47","author":"Renom-Guiteras","year":"2018","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105474_bib27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1017\/S104161021600082X","article-title":"Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study","volume":"28","author":"van der Spek","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2024.105474_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jamda.2024.03.007","article-title":"Guideline recommendations on behavioral and psychological symptoms of dementia: a systematic review","volume":"25","author":"Watt","year":"2024","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105474_bib30","author":"Beek"},{"key":"10.1016\/j.jamda.2024.105474_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac189","article-title":"Psychotropic drug treatment for agitated behaviour in dementia: what if the guideline prescribing recommendations are not sufficient? A qualitative study","volume":"51","author":"Dijk","year":"2022","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105474_bib32","first-page":"871","article-title":"Use of benzodiazepines and Z-drugs in nursing home residents with dementia: prevalence and appropriateness","volume":"5","author":"Rijksen","year":"2021","journal-title":"J\u00a0Alzheimers Dis Rep"},{"key":"10.1016\/j.jamda.2024.105474_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gps.5693","article-title":"The course of neuropsychiatric symptoms and psychotropic drug use in Dutch nursing home patients with dementia during the first wave of COVID-19: a longitudinal cohort study","volume":"37","author":"Sizoo","year":"2022","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105474_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/0305569900160305","article-title":"The Hawthorne effect: a fresh examination","volume":"16","author":"Diaper","year":"1990","journal-title":"Educ Stud"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024008971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024008971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:34:02Z","timestamp":1777361642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861024008971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1525861024008971"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105474","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to Guideline Recommendations on Psychotropic Drug Use for Challenging Behavior in Dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"105474"}}